Tag: Merck

Merck KGaA: Long Setup trotz schwacher Zahlen?

TradingAugust 17, 2023

Symbol: MRK ISIN: DE0006599905 Rückblick: Die Merck-Aktie hat im vergangenen Halbjahr rund 12 Prozent ihres Kurswertes eingebüßt. Die markante Bullenflagge der letzten...

The climate crisis and surge in melanoma cases: can a vaccine be the solution?

BiotechnologyAugust 16, 2023

Melanoma is the most serious type of skin cancer, and is primarily caused by too much exposure to ultraviolet (UV) light – in the...

A biotech scraps two cancer trials in latest setback for emerging drug class

BiotechnologyAugust 11, 2023

Dive Brief: Cancer drug developer ALX Oncology is stopping a pair of studies of its most advanced immunotherapy prospect in the latest setback for an...

Biotecnika Times Newsletter 11.08.2023 Freshers Job Merck, Project Intern, TIGS Hiring, Workshop Registrations Open + Much More

BiotechnologyAugust 11, 2023

--Must See-- Biotecnika Times Newsletter 11.08.2023 Freshers Job Merck, Project Intern, TIGS Hiring, Workshop Registrations Open + Much More Freshers Job at Merck – MSc...

2023 shaping up to be biggest year for biopharma M&A since pandemic (NYSE:PFE)

TradingAugust 6, 2023

The IPO market may still be frigid, but 2023 is shaping up to be the biggest year for biopharma...

GSK broadens use of cancer immunotherapy with latest FDA OK

BiotechnologyAugust 1, 2023

GSK on Thursday was cleared to broaden use of its cancer immunotherapy Jemperli, winning approval from the Food and Drug Administration to market the...

Vivek Ramaswamy wants to ‘gut’ the FDA. His claims don’t hold up to scrutiny

BiotechnologyJuly 31, 2023

STAT readers know Vivek Ramaswamy from his time as the founder of the biotech conglomerate Roivant — and for his role in some of...

Dyslipidemia market expected to reach $15.53bn across 7MM by 2032

Clinical TrialsJuly 28, 2023

Major drivers of the dyslipidemia market growth during the forecast period are: The increasing global prevalence of dyslipidemia...

Merck reports data from Phase III pneumococcal vaccine trials

Clinical TrialsJuly 28, 2023

US-based pharmaceutical company Merck & Co (MSD) has reported positive topline data from two Phase III clinical trials of...

Full thickness 3D in vitro conjunctiva model enables goblet cell differentiation – Scientific Reports

BiotechnologyJuly 27, 2023

Human tissueAll experimental protocols were approved by the local ethics committee (Ethik-Kommission der Universität Würzburg, approval number 280/18sc). All experiments were conducted in compliance...

AI Drug Discovery: Key Trends and Developments in Pharmaceutical Industry

BiotechnologyJuly 26, 2023

AI in Drug Discovery at a Glance The ongoing rise of artificial intelligence (AI) is significantly impacting various industries, with the pharmaceutical and biotech...

Microgravity: the future of R&D?

Medical DevicesJuly 26, 2023

Space: the final frontier…for manufacturing under microgravity conditions. Products made in space could become crucial for R&D in...

1 234...22 Page 3 of 22

Datopotamab Deruxtecan Demonstrated Statistically Significant and Clinically Meaningful Progression-Free Survival Benefit in Patients with HR-Positive, HER2-Low or Negative Breast Cancer in TROPION-Breast01 Phase III...

Clinical Trials September 22, 2023

Generative Data Intelligence

Tag: Merck

Latest Intelligence

Notice of Extraordinary General Meeting in Senzime AB (PUBL) | BioSpace

Big pharma monopolies: major antitrust cases over the past decade

Roche acquires Telavant Holdings to win TLA1 race

Multivalent insulin receptor activation using insulin–DNA origami nanostructures – Nature Nanotechnology

Sept. 28 Quick Takes: FDA approves Amicus’ Pompe disease therapy

Deglycosylation of eukaryotic-expressed flagellin restores adjuvanticity – npj Vaccines

Datopotamab Deruxtecan Demonstrated Statistically Significant and Clinically Meaningful Progression-Free Survival Benefit in Patients with HR-Positive, HER2-Low or Negative Breast Cancer in TROPION-Breast01 Phase III...